BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/8/2024 7:03:37 AM | Browse: 93 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 89459
Country/Territory Thailand
Category Genetics & Heredity
Manuscript Type Case Control Study
Article Title Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Manuscript Source Unsolicited Manuscript
All Author List Kanuengnit Choochuay, Punna Kunhapan, Apichaya Puangpetch, Sissades Tongsima, Pornpen Srisawasdi, Abhasnee Sobhonslidsuk, Somnuek Sungkanuparph, Mohitosh Biswas and Chonlaphat Sukasem
Funding Agency and Grant Number
Funding Agency Grant Number
the Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Corresponding Author Chonlaphat Sukasem, PhD, Professor, Laboratory for Pharmacogenomics, Division of Pharmacogenomics and Personalized Medicine, Somdech Phra Debaratana Medical Center (SDMC), Faculty of Medicine Ramathibodi Hospital, Mahidol University, Division of Pharmacogenomics and Personalized Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. chonlaphat.suk@mahidol.ac.th
Key Words PNPLA3; LEP; Metabolic-associated fatty liver disease; People living with HIV; Thai
Core Tip The prevalence of metabolic-associated fatty liver disease (MAFLD) in people living with human immunodeficiency virus (PLWH) is increasing, becoming a public health concern. The current evidence suggests that aspartate transaminase, fasting plasma glucose, triglyceride, total cholesterol, low-density lipoprotein, and the genetic factors PNPLA3 rs738409 and LEP rs7799039 indicate genetic susceptibility for PLWH, leading to improvements in MAFLD.
Citation Choochuay K, Kunhapan P, Puangpetch A, Tongsima S, Srisawasdi P, Sobhonslidsuk A, Sungkanuparph S, Biswas M, Sukasem C. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World J Hepatol 2024; In press
Received
2023-11-01 13:42
Peer-Review Started
2023-11-01 13:43
To Make the First Decision
Return for Revision
2023-12-06 13:10
Revised
2024-01-09 16:25
Second Decision
2024-02-08 04:45
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-02-08 07:03
Articles in Press
2024-02-08 07:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com